You are here

Contact:
Jon Dobson
202-434-7272
jdobson@advamed.org
January 4, 2017

AdvaMed Congratulates Trump Trade Picks

WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement today regarding the naming of President-elect Donald Trump’s trade team – including the nominations of Robert Lighthizer for United States Trade Representative and Wilbur Ross for Secretary of the Department of Commerce, and the appointment and Peter Navarro as head of the newly created White House Trade Council:

“AdvaMed congratulates Mr. Lighthizer and Mr. Ross on their nominations and Mr. Navarro on his new role. President-elect Trump has stressed the need for a new approach to U.S. trade policy that focuses on America’s economic growth and U.S. workers. His new trade team’s combined prior experiences in government and the private sector make clear that trade policy will be a top priority for the incoming administration.

“AdvaMed strongly supports trade policies that open and maintain access to foreign markets. We look forward to working with the new administration on ways to improve worldwide patient access to life-changing innovations from the U.S. medical technology industry, which will save and improve more patients’ lives, create more good-paying American jobs, and grow our economy.

“The U.S. medical technology industry provides employment for about 2 million people across the country – including direct and indirect employment – at salaries that are 1.85-times the national average.

“With approximately 60 percent of the global medical technology market outside the United States, trade policy plays a critical role in improving patient outcomes around the world by allowing greater access to the life-saving and life-improving medical devices and diagnostics our member companies provide.”